153 related articles for article (PubMed ID: 36305671)
1. Clinical significance of limited and extended pelvic lymph node dissection during robot-assisted radical prostatectomy for patients with localized prostate cancer: A retrospective, propensity score matching analysis.
Hori S; Nakai Y; Tachibana A; Omori C; Nishimura N; Inoue K; Tomizawa M; Shimizu T; Morizawa Y; Gotoh D; Miyake M; Torimoto K; Yoneda T; Fujimoto K; Tanaka N
Int J Urol; 2023 Feb; 30(2):168-175. PubMed ID: 36305671
[TBL] [Abstract][Full Text] [Related]
2. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
[TBL] [Abstract][Full Text] [Related]
3. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.
Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH
BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436
[TBL] [Abstract][Full Text] [Related]
4. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.
Preisser F; van den Bergh RCN; Gandaglia G; Ost P; Surcel CI; Sooriakumaran P; Montorsi F; Graefen M; van der Poel H; de la Taille A; Briganti A; Salomon L; Ploussard G; Tilki D;
J Urol; 2020 Feb; 203(2):338-343. PubMed ID: 31437119
[TBL] [Abstract][Full Text] [Related]
5. Extended robot-assisted laparoscopic prostatectomy and extended pelvic lymph node dissection as a monotherapy in patients with very high-risk prostate cancer Patients.
Miura N; Sugihara N; Funaki K; Kakuda T; Koyama K; Watanabe R; Sawada Y; Noda T; Nishimura K; Fukumoto T; Miyauchi Y; Kikugawa T; Saika T
Cancer Med; 2021 Nov; 10(22):7968-7976. PubMed ID: 34562303
[TBL] [Abstract][Full Text] [Related]
6. Impact of indocyanine green-guided extended pelvic lymph node dissection during robot-assisted radical prostatectomy.
Shimbo M; Endo F; Matsushita K; Hattori K
Int J Urol; 2020 Oct; 27(10):845-850. PubMed ID: 32634854
[TBL] [Abstract][Full Text] [Related]
7. Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?
Mitsuzuka K; Koie T; Narita S; Kaiho Y; Yoneyama T; Kawamura S; Tochigi T; Ohyama C; Habuchi T; Arai Y
Int J Urol; 2013 Nov; 20(11):1092-6. PubMed ID: 23387553
[TBL] [Abstract][Full Text] [Related]
8. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Adding Sentinel Node Biopsy to Extended Pelvic Lymph Node Dissection on Biochemical Recurrence in Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy.
Grivas N; Wit EMK; Kuusk T; KleinJan GH; Donswijk ML; van Leeuwen FWB; van der Poel HG
J Nucl Med; 2018 Feb; 59(2):204-209. PubMed ID: 28747519
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic value of pelvic lymph node dissection in the fossa of Marcille in patients with clinically localized high-risk prostate cancer: Histopathological and molecular analyses.
Bando Y; Hinata N; Terakawa T; Furukawa J; Harada K; Nakano Y; Fujisawa M
Prostate; 2020 Mar; 80(4):345-351. PubMed ID: 31899555
[TBL] [Abstract][Full Text] [Related]
11. Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy.
Morizane S; Honda M; Shimizu R; Tsounapi P; Teraoka S; Yumioka T; Yamaguchi N; Kawamoto B; Iwamoto H; Hikita K; Takenaka A
Int J Clin Oncol; 2022 Apr; 27(4):781-789. PubMed ID: 35076818
[TBL] [Abstract][Full Text] [Related]
12. Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial.
Touijer KA; Sjoberg DD; Benfante N; Laudone VP; Ehdaie B; Eastham JA; Scardino PT; Vickers A
Eur Urol Oncol; 2021 Aug; 4(4):532-539. PubMed ID: 33865797
[TBL] [Abstract][Full Text] [Related]
13. Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer.
Morizane S; Honda M; Shimizu R; Teraoka S; Nishikawa R; Tsounapi P; Kimura Y; Iwamoto H; Hikita K; Takenaka A
Int J Clin Oncol; 2020 Jul; 25(7):1398-1404. PubMed ID: 32333202
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era.
Goto Y; Utsumi T; Maruo M; Kurozumi A; Noro T; Tanaka S; Sugawara S; Chiba K; Miyazaki K; Inoue A; Komaru A; Fukasawa S; Imamura Y; Sakamoto S; Nakatsu H; Suzuki H; Ichikawa T; Nagata M
Int J Urol; 2023 Aug; 30(8):659-665. PubMed ID: 37130793
[TBL] [Abstract][Full Text] [Related]
15. Indocyanine green guidance improves the efficiency of extended pelvic lymph node dissection during laparoscopic radical prostatectomy.
Claps F; Ramírez-Backhaus M; Mir Maresma MC; Gómez-Ferrer Á; Mascarós JM; Marenco J; Collado Serra A; Casanova Ramón-Borja J; Calatrava Fons A; Trombetta C; Rubio-Briones J
Int J Urol; 2021 May; 28(5):566-572. PubMed ID: 33675069
[TBL] [Abstract][Full Text] [Related]
16. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
[TBL] [Abstract][Full Text] [Related]
17. Comparison of therapeutic features and oncologic outcome in patients with pN1 prostate cancer among robot-assisted, laparoscopic, or open radical prostatectomy.
Kirisawa T; Shiota M; Kimura T; Edamura K; Miyake M; Morizane S; Yoshino T; Matsukawa A; Matsumoto R; Kasahara T; Nishiyama N; Eto M; Kitamura H; Nakamura E; Matsui Y;
Int J Clin Oncol; 2023 Feb; 28(2):306-313. PubMed ID: 36527579
[TBL] [Abstract][Full Text] [Related]
18. Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Clin Cancer Res; 2018 May; 24(10):2342-2349. PubMed ID: 29463560
[No Abstract] [Full Text] [Related]
19. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.
Dorin RP; Lieskovsky G; Fairey AS; Cai J; Daneshmand S
Urol Oncol; 2013 Nov; 31(8):1441-7. PubMed ID: 22516714
[TBL] [Abstract][Full Text] [Related]
20. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.
Oderda M; Diamand R; Albisinni S; Calleris G; Carbone A; Falcone M; Fiard G; Gandaglia G; Marquis A; Marra G; Parola C; Pastore A; Peltier A; Ploussard G; Roumeguère T; Sanchez-Salas R; Simone G; Smelzo S; Witt JH; Gontero P
BJU Int; 2021 Mar; 127(3):318-325. PubMed ID: 32869940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
